Marco van Doeveren Recognized for Dedication to Optimizing Clinical Development for Mid-Market Companies
Medidata Solutions VP of Implementation Services Honored among 100 Most Inspiring People
Lois Paul and PartnersSusan McCarron, 617-986-5767
(NASDAQ: MDSO), a leading global provider of cloud-based clinical development solutions, today announced that vice president of implementation services Marco van Doeveren was named by magazine as one of the 100 most inspiring people in the life sciences industry.
The award recognizes Marco as a driving force behind Medidata’s success in addressing the unique challenges of mid-size and emerging companies in reaching the full benefits that advanced technology can bring to streamlining clinical trials.
Mid-market organizations – including pharmaceutical, biotech, medical device, academic, nonprofit and government – are looking to reap the same benefits as the large biopharma companies from Medidata’s cloud-based platform of innovative solutions. Implementations at mid-market companies frequently involve individual tailoring to account for fewer resources and accelerated timelines, and many smaller companies question whether they can get an industry-leading solution for a price they can afford.
Under Marco’s leadership, Medidata’s mid-market services team continually works to make optimal use of the Medidata platform by focusing on end-to-end processes. Using his sponsor-focused perspective to adapt Medidata’s implementation process for the mid-market, Marco’s group reliably streamlines trial processes and implements tailored solutions to each individual group without compromising efficiency or quality. As a result, his team has doubled revenue, tripled the number of projects and quadrupled the number of clients in a four-year span.
Established eight years ago by magazine, the 100 is an annual list of individuals recognized for their positive contributions to the life sciences industry. Nominated by thousands of readers, the 100 are selected based on well-crafted and comprehensive essays describing how individuals inspired or motivated their colleagues or peers or affected positive changes in their organizations, as well as other factors, such as community and philanthropic activities. The 100 represent a broad cross section of industry sectors, including pharmaceutical, biopharmaceutical, biotechnology, contract research, clinical trial, research and development, patient education, patient recruitment, advertising, technology and many others.
is expressly written and designed to deliver the views, opinions, and insights of executives who are shaping the direction of the dynamic life sciences industry. reaches more than 29,000 subscribers every month in print and more than 100,000 readers through its online version, which contains original exclusive bonus content. ’s unique horizontal editorial approach cuts industry silos, providing a holistic overview of the life sciences industry, addressing a range of topics from molecule through market. By engaging compelling personalities from diverse industry sectors, provides multiple perspectives on business challenges, trends, and topics. Editorial content sparks dialog, initiates debate, and opens the lines of communication to facilitate and improve business-to-business relationships. multiple-perspective and in-depth original forums, feature articles, topics, and departments are audience-driven. provides executives with useful peer-to-peer insights on a broad range of life sciences business practices and topics.
is a leading global provider of cloud-based clinical development solutions that enhance the efficiency of customers’ clinical trials. Medidata’s advanced platform lowers the total cost of clinical development by optimizing clinical trials from concept to conclusion: from study and protocol design, trial planning and budgeting, site negotiation, clinical portal, trial management, randomization and trial supply management, clinical data capture and management, safety events capture, medical coding to business analytics. Our diverse life science customer base spans biopharmaceutical companies, medical device and diagnostic companies, academic and government institutions, CROs and other research organizations, and includes more than 20 of the top 25 global pharmaceutical companies as well as organizations of all sizes developing life-enhancing medical treatments and diagnostics.